We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Whitepapers

Blue "MIMETAS" logo is positioned in the bottom left. Black background with abstract, colorful patterns resembling microscopic cells.
Whitepaper

Transforming Cancer Drug Discovery With Comprehensive Tumor Models

This whitepaper explores groundbreaking organ-on-a-chip technology and 3D tissue modeling that is closing the translational gap in cancer drug discovery.
CRISPR Science Image
Whitepaper

Empowering CRISPR With Innovative Single Cell Isolation

This whitepaper explores the advantages of a novel cell sorting and dispensing platform – which combines microfluidics, flow cytometry and liquid dispensing – that can help researchers get to their optimal clones more efficiently.
Understanding Cell-to-Cell Communication in Cancer
Whitepaper

Understanding Cell-to-Cell Communication in Cancer

This article explores how we can find new ways to stop tumor growth and prevent drug resistance by targeting the language of cancer cell communication.
 DNA damage repair
Whitepaper

How to Choose the Right Assay for PARP

When assessing PARP enzymatic activity for drug development, each component must be carefully optimized to ensure sensitivity, robustness and reproducibility. This whitepaper explores methods and reagents available to evaluate drug specificity and effectiveness.

Antibody
Whitepaper

Quantitative Assays To Accelerate Therapeutic Antibody Development

This whitepaper explores the tools available to characterize antibody binding to Fc receptors, including quantitative assays to support optimization of therapeutic products.
Cancer Research
Whitepaper

Real-Time Metabolic Analysis for Cancer Research

This brochure explores the applications of a real-time metabolic analysis platform for cancer research and cell therapeutics development.

Nanopore Sequence Still
Whitepaper

Multiomic Sequencing Solutions To Revolutionize Human Disease Research

Understanding the mechanisms of human disease requires a multiomic approach; however, legacy multiomic methods require multiple platforms and complex processes with lengthy turnaround times and considerable costs.
Cell Therapy
Whitepaper

Advances in Cell Therapy

This article examines recent advancements in cell therapy research, from promising lab findings poised for clinical translation to enhancements in development, testing, and manufacturing processes.
Enhancing Immune Cell Cytotoxicity and Persistence Insights Using Real-Time Cell Analysis
Whitepaper

Enhancing Immune Cell Cytotoxicity and Persistence Insights Using Real-Time Cell Analysis

Cell therapies, from regenerative medicine to immunotherapy, are transforming the medical landscape with 75 already approved globally and over 2,000 in development.
A healthcare worker tends to a patient receiving treatment in the hospital
Whitepaper

Improving Cancer Patient Care With Professor Mark Lawler

In this article, Mark Lawler, professor of digital health, answers your questions about these revolutionary techniques and discusses the barriers to their implementation in the clinic. Prof. Lawler has an international reputation in cancer research and a focus on developing a molecular understanding of cancer to improve patient care, including through precision medicine.
Advertisement